PortfoliosLab logo
WT vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WT and ABBV is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

WT vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree Inc. (WT) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

WT:

0.09

ABBV:

0.71

Sortino Ratio

WT:

0.37

ABBV:

0.97

Omega Ratio

WT:

1.05

ABBV:

1.15

Calmar Ratio

WT:

0.05

ABBV:

0.85

Martin Ratio

WT:

0.18

ABBV:

2.09

Ulcer Index

WT:

17.83%

ABBV:

8.49%

Daily Std Dev

WT:

34.23%

ABBV:

27.46%

Max Drawdown

WT:

-99.93%

ABBV:

-45.09%

Current Drawdown

WT:

-54.69%

ABBV:

-14.01%

Fundamentals

Market Cap

WT:

$1.34B

ABBV:

$351.09B

EPS

WT:

$0.33

ABBV:

$2.34

PE Ratio

WT:

27.67

ABBV:

84.82

PS Ratio

WT:

3.06

ABBV:

6.05

PB Ratio

WT:

3.36

ABBV:

105.59

Total Revenue (TTM)

WT:

$438.98M

ABBV:

$57.37B

Gross Profit (TTM)

WT:

$297.93M

ABBV:

$44.44B

EBITDA (TTM)

WT:

$94.88M

ABBV:

$16.33B

Returns By Period

In the year-to-date period, WT achieves a -10.10% return, which is significantly lower than ABBV's 5.83% return. Over the past 10 years, WT has underperformed ABBV with an annualized return of -4.84%, while ABBV has yielded a comparatively higher 15.80% annualized return.


WT

YTD

-10.10%

1M

11.45%

6M

-12.67%

1Y

3.00%

5Y*

27.67%

10Y*

-4.84%

ABBV

YTD

5.83%

1M

3.60%

6M

-5.73%

1Y

19.28%

5Y*

22.02%

10Y*

15.80%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WT vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WT
The Risk-Adjusted Performance Rank of WT is 5252
Overall Rank
The Sharpe Ratio Rank of WT is 5656
Sharpe Ratio Rank
The Sortino Ratio Rank of WT is 4848
Sortino Ratio Rank
The Omega Ratio Rank of WT is 4747
Omega Ratio Rank
The Calmar Ratio Rank of WT is 5454
Calmar Ratio Rank
The Martin Ratio Rank of WT is 5454
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 7373
Overall Rank
The Sharpe Ratio Rank of ABBV is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 6565
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 6868
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 8181
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 7474
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

WT vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree Inc. (WT) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current WT Sharpe Ratio is 0.09, which is lower than the ABBV Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of WT and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

WT vs. ABBV - Dividend Comparison

WT's dividend yield for the trailing twelve months is around 0.95%, less than ABBV's 3.46% yield.


TTM20242023202220212020201920182017201620152014
WT
WisdomTree Inc.
0.95%1.14%1.73%2.20%1.96%2.24%2.48%1.80%2.55%2.87%3.64%0.51%
ABBV
AbbVie Inc.
3.46%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

WT vs. ABBV - Drawdown Comparison

The maximum WT drawdown since its inception was -99.93%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for WT and ABBV. For additional features, visit the drawdowns tool.


Loading data...

Volatility

WT vs. ABBV - Volatility Comparison


Loading data...

Financials

WT vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between WisdomTree Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20212022202320242025
108.08M
13.34B
(WT) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

WT vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between WisdomTree Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%80.0%85.0%20212022202320242025
68.7%
83.9%
(WT) Gross Margin
(ABBV) Gross Margin
WT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, WisdomTree Inc. reported a gross profit of 74.29M and revenue of 108.08M. Therefore, the gross margin over that period was 68.7%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.

WT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, WisdomTree Inc. reported an operating income of 34.16M and revenue of 108.08M, resulting in an operating margin of 31.6%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.

WT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, WisdomTree Inc. reported a net income of 24.63M and revenue of 108.08M, resulting in a net margin of 22.8%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.